These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15807863)

  • 1. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.
    Möttönen M; Heikkinen J; Mustonen L; Isomäki P; Luukkainen R; Lassila O
    Clin Exp Immunol; 2005 May; 140(2):360-7. PubMed ID: 15807863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis.
    Jiao Z; Wang W; Jia R; Li J; You H; Chen L; Wang Y
    Scand J Rheumatol; 2007; 36(6):428-33. PubMed ID: 18092263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis.
    Liu MF; Wang CR; Fung LL; Lin LH; Tsai CN
    Scand J Immunol; 2005 Sep; 62(3):312-7. PubMed ID: 16179019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid.
    Hatachi S; Iwai Y; Kawano S; Morinobu S; Kobayashi M; Koshiba M; Saura R; Kurosaka M; Honjo T; Kumagai S
    J Rheumatol; 2003 Jul; 30(7):1410-9. PubMed ID: 12858435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
    van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.
    Takahata Y; Nomura A; Takada H; Ohga S; Furuno K; Hikino S; Nakayama H; Sakaguchi S; Hara T
    Exp Hematol; 2004 Jul; 32(7):622-9. PubMed ID: 15246158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.
    Cao D; Malmström V; Baecher-Allan C; Hafler D; Klareskog L; Trollmo C
    Eur J Immunol; 2003 Jan; 33(1):215-23. PubMed ID: 12594850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
    Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
    Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L; Lao SH; Wu CY
    Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
    Kao JK; Hsue YT; Lin CY
    J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
    J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.